As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment
Leaders must be adaptive, forward-thinking, and equipped to cultivate environments where humans and AI work together effectively and ethically.
Editor-in-chief Jonah Comstock sat down with pharmaphorum web editor Nicole Raleigh to discuss JPM2026.
Part One of a series of articles – Israel’s MedTech and health innovation landscape: From Tel Aviv to Jerusalem - looking at resilient progress there.
Psychiatry has spent decades focused on dopamine, serotonin, norepinephrine, and glutamate.
Editor's Picks
